All In Biotech

Drug Trial Radar · NCT05269004

A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis

A Multicenter, Single-Arm, Open-Label, Extension, Rollover Study To Evaluate The Long-Term Safety And Efficacy Of Ocrelizumab In Patients With Multiple Sclerosis

Last checked: Nov 20, 2026Latest source record: Oct 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

1,300

Planned (sponsor's estimate)

Start

May 3, 2022

Primary completion

Dec 31, 2027

Study completion Dec 31, 2027

Sponsor

Lead sponsor
Hoffmann-La RocheRoche (Genentech) (RHHBY)
Sponsor type
Industry
First posted
Mar 7, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase IIIb, single-arm, multicenter, OLE study. Participants receiving ocrelizumab as an investigational medicinal product (IMP) in a Roche sponsored Parent study who continue to receive ocrelizumab or are in safety follow-up at the time of the closure of their respective Parent study (WA21092, WA21093 or WA25046) are eligible for enrollment in this extension study. Participants who will continue ocrelizumab treatment will receive IMP based on the dosage and administration received at the time of rollover from the Parent study.

Conditions

  • Multiple Sclerosis

Interventions

  • OcrelizumabDrug

    Ocrelizumab will be administered based on the dosage and administration received at the time of rollover from the Parent study.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence and severity of adverse events, with severity determined according to the NCI CTCAE v5.0Time frame: Up to 44 months

Locations

232 sites in 37 countries. Site status is shown where the registry gives one.

  • Barrow Neurological Institute

    Phoenix, Arizona

  • Arizona Neuroscience Research LLC

    Phoenix, Arizona

  • MS Center of California

    Laguna Hills, California

  • Stanford Hospital and Clinics

    Palo Alto, California

  • University of California San Francisco

    San Francisco, California

  • University of California San Francisco

    San Francisco, California

  • University of Colorado - Anschutz Medical Campus (University of Colorado Health Sciences Center)

    Aurora, Colorado

  • Advanced Neurosciences Research LLC

    Fort Collins, Colorado

  • Neurology Associates PA

    Maitland, Florida

  • University of Miami

    Miami, Florida

  • Neurological Services of Orlando

    Orlando, Florida

  • University of South Florida

    Tampa, Florida

  • Vero Beach Neurology and Research Institute

    Vero Beach, Florida

  • Atlanta Neuroscience Institute

    Atlanta, Georgia

  • Northwestern University

    Chicago, Illinois

  • Consultants in Neurology Ltd

    Northbrook, Illinois

  • Indiana Univ School of Med

    Indianapolis, Indiana

  • Kansas University Medical Center

    Kansas City, Kansas

  • Massachusetts General Hospital

    Boston, Massachusetts

  • Wayne State University

    Detroit, Michigan

  • Henry Ford Health System

    Detroit, Michigan

  • Michigan Institute for Neurological Disorders

    Farmington Hills, Michigan

  • Minneapolis Clinic of Neurology

    Golden Valley, Minnesota

  • Washington University

    St Louis, Missouri

  • University of Nebraska Medical Center

    Omaha, Nebraska

  • Rutgers New Jersey Medical School Department of Neurology

    Newark, New Jersey

  • Holy Name Hospital

    Teaneck, New Jersey

  • University of New Mexico

    Albuquerque, New Mexico

  • SUNY at Stony Brook

    Stony Brook, New York

  • OnSite Clinical Solutions LLC

    Charlotte, North Carolina

  • The Neurological Institute PA

    Charlotte, North Carolina

  • Atrium Health

    Charlotte, North Carolina

  • Raleigh Neurology Associates

    Raleigh, North Carolina

  • University Neurology Inc.

    Cincinnati, Ohio

  • Columbus Neuroscience

    Westerville, Ohio

  • Oklahoma Medical Research Foundation

    Oklahoma City, Oklahoma

  • Providence Neurological Specialties

    Portland, Oregon

  • Abington Neurological Associates

    Abington, Pennsylvania

  • Rhode Island Hospital

    Providence, Rhode Island

  • Neurology Clinic PC

    Cordova, Tennessee

Showing 40 of 232 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.